Search results for "patient characteristics"

Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027

Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027

Daewoong Pharmaceutical has completed patient enrollment for the global Phase 2 clinical trial of bersiporosin (DWN12088), its first-in-class...
When Brushing Your Teeth Brings Shocking Pain: The Remission Trap of Trigeminal Neuralgia

When Brushing Your Teeth Brings Shocking Pain: The Remission Trap of Trigeminal Neuralgia

One day, without warning, brushing your teeth sends an agonizing, electric shock-like jolt across one side of your face.
Found a Breast Lump? Why Immediate Mammotome Removal Isn't Always the First Step

Found a Breast Lump? Why Immediate Mammotome Removal Isn't Always the First Step

While lying on the ultrasound examination table, hearing the doctor say, "I see a lump here," instantly triggers...
Does Wegovy Triple Depression Risk? Real-World Data from Korean Hospitals Yields Nuanced Findings

Does Wegovy Triple Depression Risk? Real-World Data from Korean Hospitals Yields Nuanced Findings

A recent observational study indicates that individuals taking popular GLP-1 receptor agonist obesity medications may...
Forget the 4.5-Hour Window: Why Stroke Care Means Acting Right Now

Forget the 4.5-Hour Window: Why Stroke Care Means Acting Right Now

Stroke remains one of South Korea’s leading causes of death, carrying a high risk of lasting complications or...
Sudden Cold Sweats and Blurred Vision: Why You Should Lie Down, Not Tough It Out

Sudden Cold Sweats and Blurred Vision: Why You Should Lie Down, Not Tough It Out

A sudden wave of nausea hits, cold sweat breaks out, vision blurs, ears feel plugged, and a profound weakness sweeps...
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
AI-Powered Blood Test Detects 90% of Colorectal Cancers in Korean Study

AI-Powered Blood Test Detects 90% of Colorectal Cancers in Korean Study

For many people, colorectal cancer screening feels daunting from the start. South Korea’s national cancer screening...
Recreating Autoimmune Diseases in Lab 'Mini Organs' Requires Immune Environment, Not Just Patient Cells

Recreating Autoimmune Diseases in Lab 'Mini Organs' Requires Immune Environment, Not Just Patient Cells

Even among individuals sharing a diagnosis of rheumatoid arthritis or systemic lupus erythematosus, disease progression...